WHO ICTRP trial
Rescue effect of daily infusions with Legalon® SIL in Hepatitis C Virus-infected…
EUCTR2013-000245-39-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-000245-39-DE |
|---|---|
| Public title | Rescue effect of daily infusions with Legalon® SIL in Hepatitis C Virus-infected patients who are incomplete responders to standard anti-HCV treatment. |
| Scientific title | Rescue effect of daily infusions with Legalon® SIL in Hepatitis C Virus-infected patients who are incomplete responders to standard pegylated interferon/ribavirin (dual therapy) or pegylated interferon/ribavirin plus a protease inhibitor (triple therapy): a randomized, controlled, parallel-group… |
| Primary sponsor | Rottapharm S.p.A |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Austria;Germany |
| Conditions | HCV infected patients who are incomplete responders to standard pegylated interferon/ribavirin (dual therapy) or pegylated interferon/ribavirin plus a protease inhibitor (triple therapy) MedDRA version: 16.1 Level: LLT Classification code… |
| Interventions | Trade Name: Legalon SIL Product Name: Legalon SIL Pharmaceutical Form: Powder for solution for infusion INN or Proposed INN: SILIBININ-C-2´, 3-DIHYDROGEN SUCCINATE, DISODIUM SALT CAS Number: 55254-34-7 Other descriptive name… |
| Registration date | Oct 6, 2013 |
| Target size | 190 |
| Secondary IDs | LEG-SIL-2-01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: